PRINCETON, N.J., May 11 /PRNewswire/ -- BullMarket.com (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced today that it has provided subscribers with a detailed report updating outlooks on market makers and brokers, including Interactive Brokers Group (NASDAQ:IBKR), LaBranche & Co. (NYSE:LAB), and Knight Capital Group (NASDAQ:NITE). All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today: https://www.bullmarket.com/subscribe/index.php?refer=BMR234P In its report, BullMarket.com wrote: "The 'Dutch auction' method of offering shares tends to result in higher offering (and perhaps more 'accurate') prices than the traditional IPO method and likely helps account for the fact that since debuting at $30.01, Interactive Brokers' shares have pulled back. The question is whether the shares have pulled back far enough to be attractive to investors . . ." BullMarket.com looked at the following topics, among others: -- Following Interactive Brokers' post-IPO pullback, are shares now trading at an attractive valuation? -- What are the current risks involved in an investment in Interactive Brokers? -- With LaBranche working on rolling out its electronic trading system, should investors view the stock as a potential turnaround story? -- Is Knight Capital well-positioned to weather continued trends in favor of electronic trading? About BullMarket.com: Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices. NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. Indie Research Advisors, LLC is a member of the National Association of Securities Dealers, CRD number 131926. DATASOURCE: Indie Research Advisors, LLC CONTACT: Marcie Martin for BullMarket.com, +1-888-278-5515 Web site: http://www.bullmarket.com/ https://www.bullmarket.com/subscribe/index.php?refer=BMR234P

Copyright

Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Jul 2024 até Ago 2024 Click aqui para mais gráficos Nightstar Therapeutics Plc ADS.
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Gráfico Histórico do Ativo
De Ago 2023 até Ago 2024 Click aqui para mais gráficos Nightstar Therapeutics Plc ADS.